Pfizer is paying $47.50 a share in cash for Metsera, a 43% premium on the startup’s closing price on Friday that gives the ...
But -- finally -- Pfizer is getting into the obesity drug game. This past week, the company announced it will acquire Metsera ...
12d
Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths
Shares of COVID-19 vaccine makers are trading lower Friday. Vaccine stocks fell Friday on a Washington Post report that Trump ...
A positive readout of a Rapport Therapeutics seizure medicine in a mid-stage clinical trial sent company shares soaring, as ...
Weight loss drugs have represented an enormous growth area for biotech and pharma companies over the past couple of years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback